Associate Director, Biosurgery R&D & Lifecycle Hybrid

Johnson & Johnson Innovative Medicine; Raritan (NJ); Hybrid; USD 137,000 - 236,000; Full time

Job summary

Johnson & Johnson in Raritan, NJ is seeking an Associate Director of Biosurgery, R&D Lifecycle Management (LCM) within MedTech to lead and direct development activities across the Biosurgery portfolio, delivering innovative surgical technology.

This role requires 8+ years of leadership, a BS in Engineering/Science, knowledge of Design Controls, and strong cross‑functional collaboration; travel up to 20% is expected, with relocation assistance considered for uniquely qualified candidates.

Qualifications

• BS in Engineering/Science is required; advanced degree preferred.
• Significant R&D and lifecycle management experience required.
• 8+ years of people leadership in MedTech or medical devices.
• Knowledge of Design Controls is required.
• Experience in Biosurgery products preferred.
• Willingness to travel ~20% domestically/internationally.

Responsibilities

• Provide scientific direction and leadership of R&D activities in Biosurgery LCM.
• Oversee LCM projects and identify improvements.
• Ensure project timelines and milestones are met.
• Review documentation for design control, regulatory submissions and technical reports.
• Hire, mentor staff and develop talent.
• Present programs at senior management meetings.
• Ensure compliance with Health, Safety and Environmental practices.

Skills

People leadership

Cross-functional collaboration

R&D leadership

Change leadership

Communication

Mentoring

Education

BS in Engineering/Science

MS/PhD preferred

Tools

Design Controls

Job description

Johnson & Johnson in Raritan, NJ is seeking an Associate Director of Biosurgery, R&D Lifecycle Management (LCM) within MedTech to lead and direct development activities across the Biosurgery portfolio, delivering innovative surgical technology.

This role requires 8+ years of leadership, a BS in Engineering/Science, knowledge of Design Controls, and strong cross‑functional collaboration; travel up to 20% is expected, with relocation assistance considered for uniquely qualified candidates.